Brief

Boston Scientific is set to acquire RayThera for up to $1 billion, a move aimed at expanding Boston Scientific's pipeline of investigational immunology products. The deal includes an upfront payment and additional payments contingent on achieving clinical and regulatory milestones. In separate news, China Securities Regulatory Commission Chairman Wu Qing announced measures to support the healthy development of small and medium-sized fund management companies, encouraging differentiated growth strategies. Additionally, SpaceX has surpassed Amazon in market value after three consecutive days of gains, and Alipay is undergoing its largest-ever redesign, while WeChat Pay is expected to launch an "AI exclusive card" this week. AI

The market is showing increased interest in glass substrate technology, spurred by TSMC's development plan. Several companies, including XingSen Technology, Medi-Tech, Vogue Optoelectronics, and Qibin Group, have announced their current involvement in technical reserves or R&D validation for glass substrates, indicating that mass production is still some time away. In other news, Biogen is planning to acquire RayThera for up to $1 billion to expand its immunology pipeline, and SpaceX has surpassed Amazon in market value, becoming one of the top five global companies. AI